FOSTEMSAVIR FOR USE IN HEAVILY TREATMENT-EXPERIENCED HIV-1 INFECTED INDIVIDUALS

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP17704310.6

公开号：

EP3411033A1

申请日:

2017.02.02

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

A method of attaining virologic suppression in a heavily treatment-experinced (HTE) individual infected with the HIV-1 virus involves administering to the individual a treatment regimen comprising the drug fostemsavir together with an optimized background therapy (OBT). This treatment regimen should maintain virologic suppression to a plasma HIV-1 RNA level of less than 200 copies (c)/mL for an extended period.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/